LncRNA GACAT3: A Promising Biomarker and Therapeutic Target in Human Cancers

被引:7
|
作者
Yuan, Xin [1 ]
Dong, Zihui [1 ,2 ]
Shen, Shen [1 ,2 ]
机构
[1] Zhengzhou Univ, Affiliated Hosp 1, Dept Infect Dis, Zhengzhou, Peoples R China
[2] Zhengzhou Univ, Affifiliated Hosp 1, Gene Hosp Henan Prov, Precis Med Ctr, Zhengzhou, Peoples R China
关键词
lncRNA; cancer; biomarker; GACAT3; molecular mechanisms; LONG NONCODING RNA; GASTRIC-CANCER; BREAST-CANCER; LUNG-CANCER; CELL-PROLIFERATION; PROMOTES; INVASION; EPIDEMIOLOGY; MIGRATION; LNCRNA-GACAT3;
D O I
10.3389/fcell.2022.785030
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Long non-coding RNAs (lncRNAs) are a class of functional RNA molecules that do not encode proteins and are composed of more than 200 nucleotides. LncRNAs play important roles in epigenetic and gene expression regulation. The oncogenic lncRNA GACAT3 was recently discovered to be dysregulated in many tumors. Aberrant expression of GACAT3 contributes to clinical characteristics and regulates multiple oncogenic processes. The association of GACAT3 with a variety of tumors makes it a promising biomarker for diagnosis, prognosis, and targeted therapy. In this review, we integrate the current understanding of the pathological features, biological functions, and molecular mechanisms of GACAT3 in cancer. Additionally, we provide insight into the utility of GACAT3 as an effective diagnostic and prognostic marker for specific tumors, which offers novel opportunities for targeted therapeutic intervention.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Adrenic acid: A promising biomarker and therapeutic target (Review)
    Wang, Ze
    Gao, Haoyang
    Ma, Xiaotong
    Zhu, Danlin
    Zhao, Linlin
    Xiao, Weihua
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2025, 55 (02)
  • [22] LncRNA PVT1: a Novel Therapeutic Target for Cancers
    Pan, Xuefeng
    Zheng, Guobao
    Gao, Chunfang
    CLINICAL LABORATORY, 2018, 64 (05) : 655 - 662
  • [23] LncRNA GACAT3 acts as a competing endogenous RNA of HMGA1 and alleviates cucurbitacin B-induced apoptosis of gastric cancer cells
    Lin, Yibin
    Li, Jiahui
    Ye, Shazhou
    Chen, Jiayi
    Zhang, Yanru
    Wang, Liu
    Xi, Yang
    Bu, Shizhong
    Qiu, Xiaohui
    GENE, 2018, 678 : 164 - 171
  • [24] BAG3: a new therapeutic target of human cancers?
    Zhu, Huayuan
    Liu, Peng
    Li, Jianyong
    HISTOLOGY AND HISTOPATHOLOGY, 2012, 27 (03) : 257 - 261
  • [25] STEAP1 is overexpressed in cancers: A promising therapeutic target
    Moreaux, Jerome
    Kassambara, Alboukadel
    Hose, Dirk
    Klein, Bernard
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 429 (3-4) : 148 - 155
  • [26] LncRNA HCP5 as a potential therapeutic target and prognostic biomarker for various cancers: a meta‑analysis and bioinformatics analysis
    Shao-pu Hu
    Meng-xue Ge
    Lei Gao
    Min Jiang
    Kai-wen Hu
    Cancer Cell International, 21
  • [27] microRNA: A Promising Diagnostic Biomarker and Therapeutic Target for Hepatocellular Carcinoma
    Xiaofei Li
    Wenjun Yang
    Lianqing Lou
    Yongxin Chen
    Shuang Wu
    Guoqiang Ding
    Digestive Diseases and Sciences, 2014, 59 : 1099 - 1107
  • [28] Metrnl: a promising biomarker and therapeutic target for cardiovascular and metabolic diseases
    Dong, Wen-sheng
    Hu, Can
    Hu, Min
    Gao, Yi-peng
    Hu, Yu-xin
    Li, Kang
    Ye, Yun-jia
    Zhang, Xin
    CELL COMMUNICATION AND SIGNALING, 2024, 22 (01)
  • [29] microRNA: A Promising Diagnostic Biomarker and Therapeutic Target for Hepatocellular Carcinoma
    Li, Xiaofei
    Yang, Wenjun
    Lou, Lianqing
    Chen, Yongxin
    Wu, Shuang
    Ding, Guoqiang
    DIGESTIVE DISEASES AND SCIENCES, 2014, 59 (06) : 1099 - 1107
  • [30] ARDS and aging: TYMS emerges as a promising biomarker and therapeutic target
    Li, Gang
    Yan, Ke
    Zhang, Wanyi
    Pan, Haiyan
    Guo, Pengxiang
    FRONTIERS IN IMMUNOLOGY, 2024, 15